Skip to main content
search

Contract Manufacturing

Expertise Developed Over 20 Years In The Sector

Our experience in GMP manufacturing of complex and sophisticated cell-based therapies with global reach can support your program. We offer licensed GMP manufacturing for autologous and allogeneic cell therapy products throughout the development pipeline, from translational first-in-human clinical studies to late-phase trials and commercial supply.

Our two decades of experience span autologous and allogeneic therapies across a wide range of cell types, including chimeric antigen receptor (CAR) T-cells, mesenchymal stromal cells, tumour-infiltrating lymphocytes (TILs), and human pluripotent stem cells and their derivatives.

Talk to us about your requirements
Contract Manufacturing in our GMP Facility

Explore Our Services

Supporting The Entire Product Lifecycle

From preclinical proof-of-concept through commercial launch, Cell Therapies supports every stage of your product journey under one roof. Our integrated model preserves institutional knowledge, minimizes handoff risk, and ensures regulatory continuity. With expertise in process development, GMP manufacturing, quality, analytics, logistics, and regulatory support, we provide a single partner for the entire lifecycle. This continuity enables predictable costs, faster time-to-clinic, and confidence that your therapy will reach patients safely and efficiently.

svg+xml;charset=utf

What We Manufacture

We Manufacture A Broad Range Of Cell-based Therapies

  • CAR‑T and TCR‑engineered lymphocytes (auto & allo)
  • iPSC‑derived therapeutics (immune, neuronal, epithelial)
  • Mesenchymal stromal cells & extracellular vesicles
  • Tumor‑infiltrating lymphocytes (TILs) and NK cell therapies
  • Cancer vaccines
  • Tissue Engineered Products
  • Regenerative Medicine Advanced Therapies and Devices
  • Drug Substance to Drug Product
  • Cell suspension for injection
  • Viral & non‑viral gene‑modified cell products
View our servicesTalk to us
Secret Link